Novo Nordisk just introduced a GLP-1 pill, but the company makes more than just weight-loss drugs.
Pfizer is expected to post fourth-quarter adjusted earnings of 57 cents a share on revenue of $16.85 billion, according to analysts polled by FactSet. That compares with adjusted earnings of 63 cents ...
“Pfizer appears cheap with a near 7% yield, but capital allocation constraints undermine its investment case. Nearly all of ...
BMY heads into Q4 2025 earnings with strong Opdivo momentum, even as generic pressure continues to weigh on legacy drug sales ...
Pfizer is almost certain to survive the current headwinds as a business. However, the dividend may not. It will be important ...
The Morning Bull - US Market Morning Update Monday, Feb, 2 2026 US stock futures are pointing lower this morning, with E mini S&P 500 contracts down about 0.7% and Nasdaq 100 futures off just over 1%, ...
Earnings season marches on. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report this week, following on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results